Joey sold his business and felt like he was living the American dream when his life was turned upside down in 2019. He was diagnosed with metastatic bladder cancer.
“I remember I was trying to call my wife to talk to her,” recalls Joey. “And then I couldn't speak.”
“We simply can’t be at our best unless our people are at their best.”
Blog
“Protecting the health and safety of P&G people is our first priority. It’s also key to enabling a superior employee experience so we can, in turn, deliver superiority for our customers and consumers,” said Chief Human Resources Officer Tracey Grabowski.
“Wellness has come into sharp focus over the past two years, but our goal at P&G is to make well-being a priority that enables maximized business impact year after year,” she said. “We simply can’t be at our best unless our people are at their best.”
In the second installment of our two-part series, we explore the risks inherent in Bluetooth Low Energy communication chipsets which can directly impact product functionality and patient safety.
In the first of our two-part series, we are exploring the background of Bluetooth Low Energy and how it is transforming the world of connected medical devices.
Commitment recognized by White House Cancer Moonshot
Georgetown University to establish the Ralph Lauren Center for Cancer Prevention at Georgetown Lombardi Comprehensive Cancer Center in Washington, D.C.
Memorial Sloan Kettering (MSK) Ralph Lauren Center to build upon 20-year partnership serving Harlem, New York, and surrounding communities
Conquer Cancer®, the ASCO Foundation, to collaborate on the Ralph Lauren Corporate Foundation’s selection of three additional National Cancer Institute-designated center grant recipients
Press Release
Commitment recognized by White House Cancer Moonshot
Georgetown University to establish the Ralph Lauren Center for Cancer Prevention at Georgetown Lombardi Comprehensive Cancer Center in Washington, D.C.
Memorial Sloan Kettering (MSK) Ralph Lauren Center to build upon 20-year partnership serving Harlem, New York, and surrounding communities
Conquer Cancer®, the ASCO Foundation, to collaborate on the Ralph Lauren Corporate Foundation’s selection of three additional National Cancer Institute-designated center grant recipients
This blog was written by Aidan Burke. Aidan is a Workforce Development Administrator for Red River Technology, an IT company out of Claremont, New Hampshire, and a Cisco Networking Academy partner. I am proud of everything that Aidan has accomplished, and I hope you are inspired as you learn more about his journey.
If you get nothing out of what I am about to say — know that you matter. Whatever your struggles in life may be, you are not alone, and help is there for those that ask.
Learn how Mimi personalizes the hearing experience and makes it healthier and sustainable using Cadence® Tensilica® HiFi DSPs. The Cadence Tensilica HiFi 1 digital signal processor (DSP) is the smallest and lowest power member of the HiFi DSP family, developed for battery- constrained applications, such as mobile, hearables, wearables, laptop, automotive, and the internet of things (IOT).
A podcast with Jennifer McVean, MD, medical affairs director at Medtronic’s diabetes business
Multimedia with summary
In this episode, Jennifer McVean, MD, medical affairs director at Medtronic’s diabetes business, shares how a devastating childhood diagnosis started her on her mission to help people with diabetes. McVean used that inspiration to push her through medical school and a career in treating children. Now, she’s taking her skills and experience to Medtronic. Hear why she’s excited about the move and grateful to Medtronic technology.
NEW YORK, May 9, 2022 /3BL Media/ - WaterAid and The VF Foundation announce the launch of a year-long program to reach more than 85,000 people with access to clean water, sanitation and hygiene in Cambodia.
First-of-its-kind partnership will identify drug targets and accelerate novel therapy development using genomics and artificial intelligence
Press Release
SAN DIEGO, May 5, 2022 /3BL Media/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Deerfield Management, a healthcare investment management firm, today announced a five-year partnership to apply a genetic-led approach to the discovery and development of novel therapies for diseases with unmet medical needs. The partnership aims to leverage genomic tools and genetic knowledge to select programs with a higher probability of success in order to lower research and development costs and accelerate the approval of cutting-edge therapies.
